Replies to post #30694 on Plandai Biotechnology Inc (PLPL)

[tntgraham]

I don’t think you understood what I’m talking about

[Kool Aid Man]

"Prices for public shells vary but plan on spending between $100,000 and $500,000 plus you will have due diligence costs. You will need very good legal advice and I'd pad your budget for extra legal costs....(more)
https://www.quora.com/What-is-the-cost-to-buy-a-public-shell-company

Here's a list of OTC tickers for sale...many with an O/S a fraction of the size of PLPL's which had 7.75 BILLION shares outstanding before Byoplanet arrived in March. https://dealstream.com/financial/public-shells Rick apparently decided not to "buy" but to "reverse merge" his way into gaining control of a public ticker.

So it baffles me that, with all his purported millions, he didn't just buy a ticker outright...one with a low O/S. As it currently stands (.0008) $1 million = 1.25 billion shares in the open market. And what if he did...the O/S would still be 8.2 billion. The only difference being those 1.25 billion shares would be in his hands instead of owned by others here. I guess that might be interpreted as insuring he wouldn't dump them right away and drive the price down.

IMO if Byoplanet is financially successful and set for exponential growth then why would Rick want to go public if he didn't need the money... or didn't want to risk his own? I look at the last line on the last page of this disclosure which says that for all of 2022 Byoplanet had "NET INCOME of $142k"
https://www.otcmarkets.com/otcapi/company/financial-report/361195/content

One can have billions in revenues but, at the end of the day, "net income" is the name of the game.

IF Rick truly wants to buy back shares common sense says he will want to do it for the lowest cost possible. Whether he will take any action to facilitate a lower price remains to be seen